Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Genetic Predisposition

3-iodobenzylguanidine has been researched along with Genetic Predisposition in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Bardai, A; Blom, MT; Karemaker, JM; Tan, HL; Verberne, HJ1
Almeida, AG; Bordalo e Sá, A; Cantinho, G; Conceição, I; Cortez-Dias, N; Coutinho, MC; de Carvalho, M; Diogo, AN; Gonçalves, S; Oliveira, A1
Barone, P; Cuocolo, A; De Michele, G; De Rosa, A; Pappatà, S; Pellecchia, MT; Pellegrino, T; Peluso, S; Saccà, F1
Hasegawa, K; Kowa, H; Stoessl, AJ; Wszolek, ZK; Yagishita, S; Yokoyama, T1
Alzualde, A; Bergareche, A; Gorostidi, A; Goyenechea, E; López de Munain, A; Martí Massó, JF; Moreno, F; Poza, JJ; Rodríguez, F; Ruiz-Martínez, J1
Giubellino, A; Pacak, K; Shah, U1
Kjaer, A; Petersen, CL1
Clark, OH; Duh, QY; Kebebew, E; Zarnegar, R1

Reviews

2 review(s) available for 3-iodobenzylguanidine and Genetic Predisposition

ArticleYear
Pheochromocytoma: implications in tumorigenesis and the actual management.
    Minerva endocrinologica, 2012, Volume: 37, Issue:2

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents; Catecholamines; Cell Hypoxia; Combined Modality Therapy; Diagnosis, Differential; Disease Management; Embolization, Therapeutic; Genes, Neurofibromatosis 1; Genetic Predisposition to Disease; Humans; Hypertension; Iodine Radioisotopes; Mutation; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Pheochromocytoma; Prognosis; Proto-Oncogene Proteins c-ret; Succinate Dehydrogenase; Von Hippel-Lindau Tumor Suppressor Protein

2012
Malignant pheochromocytoma.
    Surgical oncology clinics of North America, 2006, Volume: 15, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Genetic Predisposition to Disease; Humans; Laparoscopy; Liver Neoplasms; Pheochromocytoma; Radiopharmaceuticals; Tomography, X-Ray Computed

2006

Other Studies

6 other study(ies) available for 3-iodobenzylguanidine and Genetic Predisposition

ArticleYear
An inherited sudden cardiac arrest syndrome may be based on primary myocardial and autonomic nervous system abnormalities.
    Heart rhythm, 2022, Volume: 19, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System; Baroreflex; Death, Sudden, Cardiac; Female; Genetic Predisposition to Disease; Haplotypes; Heart Defects, Congenital; Heart Rate; Humans; Male; Middle Aged; Nervous System Malformations; Radionuclide Imaging; Syndrome; Ventricular Fibrillation

2022
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
    Circulation. Cardiovascular imaging, 2013, Volume: 6, Issue:5

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Cardiomyopathies; Echocardiography; Electrocardiography, Ambulatory; Female; Genetic Predisposition to Disease; Heart; Humans; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Mutation; Phenotype; Prealbumin; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sympathetic Nervous System; Time Factors; Young Adult

2013
Myocardial
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Female; Genetic Predisposition to Disease; Heart; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Polymorphism, Single Nucleotide; Radionuclide Imaging; Radiopharmaceuticals; Ubiquitin-Protein Ligases

2017
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Isoleucine; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Tetrabenazine; Tyrosine

2009
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Taste

2011
Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:12

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Liver Neoplasms; Male; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Radionuclide Imaging; Siblings; Tomography, X-Ray Computed

2002